Evos
Payments companies reported to CMS as associated with Evos. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Evos, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Evos
These are the largest totals companies reported as associated with Evos. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Tornetta | Boston, MA | Orthopaedic Surgery | $9,163,859.84 |
| William Ricci | New York, NY | Orthopaedic Surgery | $6,158,367.23 |
| Samir Mehta | Philadelphia, PA | Orthopaedic Surgery | $1,708,427.75 |
| Reza Firoozabadi | Seattle, WA | Orthopaedic Trauma | $842,978.18 |
| John Watson | Saint Louis, MO | Orthopaedic Surgery | $621,160.29 |
| Stuart Gold | Torrance, CA | Orthopaedic Surgery | $446,944.99 |
| Hassan Mir | Temple Terrace, FL | Orthopaedic Trauma | $316,312.52 |
| Ravi Karia | San Antonio, TX | Orthopaedic Surgery | $294,616.84 |
| Roy Sanders | Temple Terrace, FL | Orthopaedic Surgery | $258,058.71 |
| Michael Beebe | Memphis, TN | Orthopaedic Surgery | $254,843.82 |
Prescribed Evos?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.